<html>
<head>
<!--center><h2> About Me</ih2></center-->
    <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="chrome=1">
<meta name="HandheldFriendly" content="True">
<meta name="MobileOptimized" content="320">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta name="referrer" content="no-referrer">

<meta name="description" content="Seke Keretsu.">



<style>
div {
  max-width: 1000px;
  min-width: 100px;
  background-color:#D3D3D3;
  text-align:justify;	
  text-indent:50px; 
}
</style>


</head>
<center>

<body>
<div>
<style>
.topnav {
  overflow: hidden;
  background-color: #333;
}

.topnav a {
  float: left;
  color: #f2f2f2;
  text-align: center;
  padding: 14px 16px;
  text-decoration: none;
  font-size: 17px;
}

.topnav a:hover {
  background-color: #ddd;
  color: black;
}

.topnav a.active {
  background-color: #4CAF50;
  color: white;
}
</style>
</head>
<body>

<div class="topnav">
  <a class="active" href="#home">Home</a>
  <a href="#news">Research</a>
  <a href="#contact">Publication</a>
  <a href="#about">Software</a>
  <a href="#tutorials">Tutorial</a>
   <a href="#Contact">Contact</a>
</div>


<div>
Selected PUBLICATIONS

1.	Keretsu, S., & Sarmah, R. (2016). Weighted edge based clustering to identify protein complexes in protein–protein interaction networks incorporating gene expression profile. Computational biology and chemistry, 65, 69-79.
2.	Keretsu, S., Bhujbal, S. P., & Cho, S. J. (2019) Computational study of paroxetine-like inhibitors reveals new molecular insight to inhibit GRK2 with selectivity over ROCK1. Scientific reports, 9(1), 1-14. 
3.	Keretsu, S., Bhujbal, S. P., & Cho, S. J. (2019). Docking and 3D-QSAR Studies of Hydrazone and Triazole Derivatives for Selective Inhibition of GRK2 over ROCK2. Letter in Drug Design and Discovery, 17(5), 618-632.
4.	Keretsu, S., Bhujbal, S. P., & Cho, S. J. (2020). Molecular modeling studies of pyrrolo[2,3-d]pyrimidin-4-amine derivatives as JAK1 inhibitors based on 3D-QSAR, molecular docking, molecular dynamics (MD) and MM-PBSA calculations. Journal of Biomolecular Structure and Dynamics, 1-13.
5.	Keretsu S, Bhujbal SP, Cho SJ (2020). Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation. Scientific reports, 10(1), 17716. 
[https://doi.org/10.1038/s41598-020-74468-0]. 
6.	Keretsu S, Ghosh S., Cho S. J. (2020). Molecular Modelling Study of c-KIT/PDGFRα Dual Inhibitors for the Treatment of Gastrointestinal Stromal Tumors. International Journal of Molecular Sciences, 21(21), 8232.

Other PUBLICATIONS

7.	Keretsu, S., & Sarmah, R. (2017). Identification of protein complexes in protein-protein interaction networks by core-attachment approach incorporating gene expression profile. International Journal of Bioinformatics Research and Applications, 13(4), 313-328.
8.	Keretsu, S., Balasubramanian, P. K., Bhujbal, S. P., & Cho, S. J. (2017). Receptor‐guided 3D‐Quantitative Structure–Activity Relationship and Docking Studies of 6‐Substituted 2‐Arylaminopurines as CDK2 Kinase Inhibitors. Bulletin of the Korean Chemical Society, 38(11), 1275-1284.
9.	Bhujbal, S. P., Keretsu, S., & Cho, S. J. (2019). Receptor‐guided 3D‐QSAR Study of Anilinoquinazolines as RET Receptor Tyrosine Kinase Antagonists. Bulletin of the Korean Chemical Society, 40(3), 207-213.
10.	Bhujbal, S. P., Keretsu, S., & Cho, S. J. (2019). Macrocyclic effect on inhibitory activity: a modeling study on MerTK inhibitors. Medicinal Chemistry Research, 1-16.
11.	Bhujbal, S. P., Keretsu, S., & Cho, S. J. (2019). A combined molecular docking and 3D-QSAR studies on tetrahydropteridin derivatives as PLK2 antagonists. Bulletin of the Korean Chemical Society, 40(8), 796-802.
12.	Bhujbal, S. P., Keretsu, S., & Cho, S. J. (2019). Design of New Therapeutic Agents Targeting FLT3 Receptor Tyrosine Kinase Using Molecular Docking and 3D-QSAR Approach. Letter in Drug Design and Discovery, 17(5), 585-596.
13.	Keretsu, S., Bhujbal, S. P., & Cho, S. J. (2020). Computational study of pyrimidin-2-aminopyrazol-hydroxamate based JAK2 inhibitors for the treatment of Myeloproliferative Neoplasms (MNPs). Bulletin of the Korean Chemical Society,  41(5), 542-551. 
14.	Bhujbal, S. P., Keretsu, S., & Cho, S. J. (2019). Molecular modelling studies on pyrazole derivatives for the design of potent RET kinase inhibitors. Molecules (accepted)


</div>


<center>
<footer class="flex-container footer">Copyright © 2021. Seke Keretsu. All rights reserved.
</footer>
</center>
</body>
</center>
</html>
